SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-000748
Filing Date
2024-05-13
Accepted
2024-05-13 06:50:43
Documents
64
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lptx-20240331x10q.htm   iXBRL 10-Q 1204622
2 EX-10.1 lptx-20240331xex10d1.htm EX-10.1 21998
3 EX-31.1 lptx-20240331xex31d1.htm EX-31.1 11085
4 EX-32.1 lptx-20240331xex32d1.htm EX-32.1 6642
  Complete submission text file 0001410578-24-000748.txt   5796336

Data Files

Seq Description Document Type Size
5 EX-101.SCH lptx-20240331.xsd EX-101.SCH 45507
6 EX-101.CAL lptx-20240331_cal.xml EX-101.CAL 37661
7 EX-101.DEF lptx-20240331_def.xml EX-101.DEF 179426
8 EX-101.LAB lptx-20240331_lab.xml EX-101.LAB 424734
9 EX-101.PRE lptx-20240331_pre.xml EX-101.PRE 306922
68 EXTRACTED XBRL INSTANCE DOCUMENT lptx-20240331x10q_htm.xml XML 900013
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 24936816
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)